Compounds > ro 31-8220
Page last updated: 2024-08-16

ro 31-8220 and sl0101

ro 31-8220 has been researched along with sl0101 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alessi, DR; Arthur, JS; Bain, J; Cohen, P; Elliott, M; Hastie, CJ; Klevernic, I; McLauchlan, H; Plater, L; Shpiro, N1
Huang, J; Li, H; Liu, X; Xu, Y; Xue, M; Yuan, J; Zhao, X; Zhao, Z; Zhong, Y1
Gussio, R; Hecht, SM; Lannigan, DA; Nguyen, TL; Scudiero, DA; Shoemaker, RH; Smith, JA; Zaharevitz, DW1

Other Studies

3 other study(ies) available for ro 31-8220 and sl0101

ArticleYear
The selectivity of protein kinase inhibitors: a further update.
    The Biochemical journal, 2007, Dec-15, Volume: 408, Issue:3

    Topics: Amino Acid Sequence; Animals; Cell Line; Drug Design; Enzyme Activation; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Recombinant Proteins; Spodoptera

2007
Substituted indolin-2-ones as p90 ribosomal S6 protein kinase 2 (RSK2) inhibitors: Molecular docking simulation and structure-activity relationship analysis.
    Bioorganic & medicinal chemistry, 2013, Apr-01, Volume: 21, Issue:7

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; Indoles; Male; Molecular Docking Simulation; Prostatic Neoplasms; Protein Kinase Inhibitors; Ribosomal Protein S6 Kinases, 90-kDa; Structure-Activity Relationship

2013
Homology model of RSK2 N-terminal kinase domain, structure-based identification of novel RSK2 inhibitors, and preliminary common pharmacophore.
    Bioorganic & medicinal chemistry, 2006, Sep-01, Volume: 14, Issue:17

    Topics: Benzopyrans; Binding Sites; Indoles; Kaempferols; Models, Molecular; Monosaccharides; Naphthalenes; Protein Conformation; Protein Structure, Tertiary; Pyrimidines; Ribosomal Protein S6 Kinases, 90-kDa; Structure-Activity Relationship

2006